8,918
Total Claims
$1.0M
Drug Cost
631
Beneficiaries
$1,596
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-95%
Opioid rate vs peers
0.1% vs 2.6% avg
+49%
Cost per patient vs peers
$1,596 vs $1,068 avg
+26%
Brand preference vs peers
11.3% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$84
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
89% generic
Brand: 1,000 claims · $802K
Generic: 7,848 claims · $198K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 78 | $171K |
| Sitagliptin Phosphate | 54 | $83K |
| Apixaban | 58 | $78K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $39K |
| Insulin Detemir | 29 | $39K |
| Rivaroxaban | 23 | $34K |
| Insulin Lispro | 11 | $31K |
| Fluticasone/Umeclidin/Vilanter | 24 | $27K |
| Tiotropium Bromide | 23 | $24K |
| Semaglutide | 18 | $22K |
| Insulin Aspart | 13 | $20K |
| Estrogens, Conjugated | 19 | $10K |
| Mometasone/Formoterol | 14 | $10K |
| Budesonide/Formoterol Fumarate | 11 | $9,649 |
| Fluticasone Propion/Salmeterol | 22 | $8,074 |
Prescribing Profile
Patient Profile
75
Avg Age
55%
Female
1.21
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data